Harbor Advisors LLC Gilead Sciences, Inc. Transaction History

Harbor Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $360,000 - $410,759	-6,000 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$72.34 - $84.0 $144,680 - $168,000	2,000 Added 50.0%	6,000 $462,000
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $187,590 - $210,150	-3,000 Reduced 42.86%	4,000 $260,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,000	7,000 $495,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Harbor Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Advisors LLC with notifications on news.